| Jun 17 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 181.56K |
| Gross Profit | $ 72.63K |
| Operating Income | $ -91.58K |
| EBITDA | $ -91.58K |
| Net Income | $ -91.52K |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 1.16K |
| Total Assets | $ 304.05K |
| Total Debt | $ 250.00K |
| Net Debt | $ 248.84K |
| Total Liabilities | $ 863.34K |
| Stockholders' Equity | $ -549.48K |
| Cash Flow | |
| Free Cash Flow | $ -17.60K |
| Operating Cash Flow | $ -17.60K |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 18.00K |
PharmaRoth Labs Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.